Cargando…
Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case–Control Study
Background: To investigate the association between proton pump inhibitor (PPI) exposure and a risk of type 2 diabetes mellitus (T2DM) among patients with upper gastrointestinal disease (UGID). Method: We conducted a case–control study from Taiwan’s National Health Insurance Research Database between...
Autores principales: | Kuo, Hsin-Ya, Liang, Chih-Sung, Tsai, Shih-Jen, Chen, Tzeng-Ji, Chu, Che-Sheng, Chen, Mu-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316003/ https://www.ncbi.nlm.nih.gov/pubmed/35886592 http://dx.doi.org/10.3390/ijerph19148739 |
Ejemplares similares
-
Multimorbidity Pattern and Risk for Mortality Among Patients With Dementia: A Nationwide Cohort Study Using Latent Class Analysis
por: Chu, Che-Sheng, et al.
Publicado: (2023) -
Risks of Major Mental Disorders and Irritable Bowel Syndrome among the Offspring of Parents with Irritable Bowel Syndrome: A Nationwide Study
por: Yeh, Ta-Chuan, et al.
Publicado: (2021) -
No association between proton pump inhibitor use and ALS risk: a nationwide nested case–control study
por: Cetin, Hakan, et al.
Publicado: (2020) -
Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study
por: Lin, Sheng-Hong, et al.
Publicado: (2021) -
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use
por: Blank, Mei-Ling, et al.
Publicado: (2014)